These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34958247)

  • 21. Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.
    Suzuki E; Koyama K; Nakai D; Goda R; Kuga H; Chiba K
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):965-972. PubMed ID: 28447323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients.
    Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Xiao J; Chen XP
    J Clin Pharm Ther; 2017 Apr; 42(2):221-227. PubMed ID: 28145574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
    Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL
    Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meropenem as an antidote for intentional valproic acid overdose.
    Thomas C; Priano J; Smith TL
    Am J Emerg Med; 2020 Mar; 38(3):690.e1-690.e2. PubMed ID: 31980292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of valproic acid overdose with meropenem in an epileptic patient.
    Cunningham D; Clark K; Lord K
    Am J Emerg Med; 2022 Mar; 53():284.e1-284.e3. PubMed ID: 34625331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Tsukahara M; So R; Yoshimura Y; Yamashita R; Yada Y; Kodama M; Nakajima S; Kishi Y; Takeda T; Yamada N; Takeuchi H
    Acta Psychiatr Scand; 2023 Nov; 148(5):437-446. PubMed ID: 37681448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenems as Antidotes for the Management of Acute Valproic Acid Poisoning.
    Perković Vukčević N; Mijatović Jovin V; Vuković Ercegović G; Antunović M; Kelečević I; Živanović D; Vučinić S
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics.
    Nakamura Y; Nakahira K; Mizutani T
    Drug Metab Lett; 2008 Dec; 2(4):280-5. PubMed ID: 19356106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seizures from valproate-carbapenem interaction.
    Taha FA; Hammond DN; Sheth RD
    Pediatr Neurol; 2013 Oct; 49(4):279-81. PubMed ID: 23932807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between valproic acid and meropenem or ertapenem in patients with epilepsy: clinical relevance and results from pharmaceutical intervention.
    Hernández-Ramos JA; Caro-Telle JM; Bruni-Montero MÁ; Canales-Siguero D; Ferrari-Piquero JM
    Farm Hosp; 2021 Sep; 45(6):335-339. PubMed ID: 34806574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of valproic acid and its six metabolites in human serum using LC-MS/MS and application to interaction with carbapenems in epileptic patients.
    Yang X; Jiang Z; Jiang Y; Ling J; Dong L; Zou S; Chen R; Hu N
    Biomed Chromatogr; 2023 Mar; 37(3):e5572. PubMed ID: 36520520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism.
    Smith RL; Kyllesø L; Haslemo T; Andreassen OA; Molden E
    Ther Drug Monit; 2019 Aug; 41(4):503-508. PubMed ID: 31259880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase.
    Ishikawa T; Otaki H; Mizuta S; Kuriyama M; Onomura O; Higuchi N; Nakashima MN; Nakashima M; Ohyama K
    Drug Metab Pharmacokinet; 2017 Aug; 32(4):201-207. PubMed ID: 28734645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.